Open access
Jul 2026
Impact of disease-modifying therapies in adults with concomitant psoriatic and metabolic liver disease with integrated immunoprofiling
In PsD, only IL-17i were associated with improved liver disease in addition to improving clinical PsD outcomes, and t-cell subtypes bridging innate and adaptive immunity were associated with liver disease features.
S. Gunawardana, L. James, C. Diamond et al.
· medRxiv · 0 citations